SciVision Biotech Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 164.9 million compared to TWD 127.27 million a year ago. Net income was TWD 45.54 million compared to TWD 20.09 million a year ago. Basic earnings per share from continuing operations was TWD 0.69 compared to TWD 0.3 a year ago. Diluted earnings per share from continuing operations was TWD 0.69 compared to TWD 0.3 a year ago.
For the nine months, sales was TWD 397.48 million compared to TWD 365.3 million a year ago. Net income was TWD 112.17 million compared to TWD 76.35 million a year ago. Basic earnings per share from continuing operations was TWD 1.69 compared to TWD 1.15 a year ago. Diluted earnings per share from continuing operations was TWD 1.69 compared to TWD 1.13 a year ago.